tiprankstipranks
Trending News
More News >

Nephros Amends CFO Employment Terms for Strategic Growth

Story Highlights
  • Nephros amended CFO Judith Krandel’s employment terms, granting two 10-year stock options.
  • The amendment ties vesting conditions to strategic transactions and increases her bonus target to 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nephros Amends CFO Employment Terms for Strategic Growth

Nephros ( (NEPH) ) has provided an announcement.

On February 26, 2025, Nephros, Inc. amended the employment terms of its Chief Financial Officer, Judith Krandel. The amendment grants Ms. Krandel two 10-year stock options under the company’s 2024 Equity Incentive Plan, with specific vesting conditions tied to her continued employment and the company’s strategic transactions. Additionally, her annual performance bonus target is increased to 30% of her base salary. This amendment could potentially strengthen the company’s leadership stability and incentivize growth-oriented strategies.

More about Nephros

YTD Price Performance: 3.42%

Average Trading Volume: 12,602

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $15.92M

See more insights into NEPH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App